Heng Yu Selected Research

Heng Yu Research Topics

Disease

8	Neoplasms (Cancer) 02/2022 - 12/2008
8	Stomach Neoplasms (Stomach Cancer) 02/2022 - 01/2021
3	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 01/2016
3	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2021
2	Necrosis 02/2022 - 01/2016
2	Heart Failure 01/2021 - 09/2017
1	Colorectal Neoplasms (Colorectal Cancer) 08/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2021
1	Carcinogenesis 01/2021
1	Pathologic Complete Response 01/2021
1	Albuminuria 01/2021
1	Glioma (Gliomas) 01/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 05/2019
1	Lung Neoplasms (Lung Cancer) 12/2018
1	Seizures (Absence Seizure) 05/2018
1	Epilepsy (Aura) 05/2018
1	Takotsubo Cardiomyopathy 05/2018
1	Hypertension (High Blood Pressure) 09/2017
1	Brain Ischemia (Cerebral Ischemia) 11/2016
1	Reperfusion Injury 11/2016
1	Infarction (Infarctions) 11/2016
1	Body Weight (Weight, Body) 11/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2015
1	Pneumoperitoneum 10/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2008
3	Biomarkers (Surrogate Marker)IBA 08/2021 - 01/2021
3	Biological ProductsIBA 08/2021 - 01/2016
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 02/2022 - 01/2021
2	TenascinIBA 12/2021 - 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022
1	Histidine (L-Histidine)FDA Link 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Calcium-Binding ProteinsIBA 01/2022
1	VimentinIBA 08/2021
1	Tyrosine Kinase InhibitorsIBA 08/2021
1	Competitive Endogenous RNAIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Ki-67 Antigen (Ki 67 Antigen)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Apolipoprotein C-II (ApoC2)IBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	Blood Proteins (Serum Proteins)IBA 12/2018
1	ellagitanninIBA 05/2018
1	Pentylenetetrazole (Metrazol)IBA 05/2018
1	corilaginIBA 05/2018
1	Valsartan (Vals)FDA Link 09/2017
1	Enalapril FDA LinkGeneric 09/2017
1	Angiotensin Receptor AntagonistsIBA 09/2017
1	sacubitril and valsartan sodium hydrate drug combinationIBA 09/2017
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2017
1	Neprilysin (Neutral Endopeptidase)IBA 09/2017
1	Neuroprotective AgentsIBA 11/2016
1	Phosphotransferases (Kinase)IBA 11/2016
1	Superoxide DismutaseIBA 11/2016
1	Dronabinol (THC)FDA LinkGeneric 11/2016
1	triphenyltetrazoliumIBA 11/2016
1	tetrahydrocurcuminIBA 11/2016
1	Malondialdehyde (Propanedial)IBA 11/2016
1	Sorafenib (BAY 43-9006)FDA Link 01/2016
1	Insulin (Novolin)FDA Link 11/2015
1	Triglycerides (Triacylglycerol)IBA 11/2015
1	Glucose (Dextrose)FDA LinkGeneric 11/2015
1	Nonesterified Fatty Acids (NEFA)IBA 11/2015
1	Angiotensin-Converting Enzyme 2IBA 11/2015
1	AngiotensinsIBA 11/2015

Therapy/Procedure

7	Therapeutics 02/2022 - 01/2016
3	Drug Therapy (Chemotherapy) 12/2021 - 01/2016
1	Adjuvant Chemotherapy 12/2021
1	Neoadjuvant Therapy 01/2021
1	Operative Surgical Procedures 05/2019
1	Castration 01/2019
1	Endoscopes 10/2012